Cargando…

CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection

The chemokine CCL7 (MCP3) is known to promote the recruitment of many innate immune cell types including monocytes and neutrophils to sites of bacterial and viral infection and eosinophils and basophils to sites of allergic inflammation. CCL7 upregulation has been associated with many inflammatory s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, Jill, Hughson, Angela, Lim, Kihong, Bardina, Susana V., Lu, Wuyuan, Charo, Israel F., Lim, Jean K., Fowell, Deborah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331479/
https://www.ncbi.nlm.nih.gov/pubmed/30671055
http://dx.doi.org/10.3389/fimmu.2018.03063
_version_ 1783387140250402816
author Ford, Jill
Hughson, Angela
Lim, Kihong
Bardina, Susana V.
Lu, Wuyuan
Charo, Israel F.
Lim, Jean K.
Fowell, Deborah J.
author_facet Ford, Jill
Hughson, Angela
Lim, Kihong
Bardina, Susana V.
Lu, Wuyuan
Charo, Israel F.
Lim, Jean K.
Fowell, Deborah J.
author_sort Ford, Jill
collection PubMed
description The chemokine CCL7 (MCP3) is known to promote the recruitment of many innate immune cell types including monocytes and neutrophils to sites of bacterial and viral infection and eosinophils and basophils to sites of allergic inflammation. CCL7 upregulation has been associated with many inflammatory settings including infection, cardiovascular disease, and the tumor microenvironment. CCL7's pleotropic effects are due in part to its ability to bind numerous chemokine receptors, namely CCR1, CCR2, CCR3, CCR5, and CCR10. CCL7-blockade or CCL7-deficiency is often marked by decreased inflammation and poor pathogen control. In the context of Leishmania major infection, CCL7 is specifically upregulated in the skin one-2 weeks after infection but its role in L. major control is unclear. To determine CCL7's impact on the response to L. major we infected WT and CCL7(−/−) C57BL/6 mice. L. major infection of CCL7-deficient mice led to an unexpected increase in inflammation in the infected skin 2 weeks post-infection. A broad increase in immune cell subsets was observed but was dominated by enhanced neutrophilic infiltration. Increased neutrophil recruitment was associated with an enhanced IL-17 gene profile in the infected skin. CCL7 was shown to directly antagonize neutrophil migration in vitro and CCL7 add-back in vivo specifically reduced neutrophil influx into the infected skin revealing an unexpected role for CCL7 in limiting neutrophil recruitment during L. major infection. Enhanced neutrophilic infiltration in CCL7-deficient mice changed the balance of L. major infected host cells with an increase in the ratio of infected neutrophils over monocytes/macrophages. To determine the consequence of CCL7 deficiency on L. major control we analyzed parasite load cutaneously at the site of infection and viscerally in the draining LN and spleen. The CCL7(−/−) mice supported robust cutaneous parasite control similar to their WT C57BL/6 counterparts. In contrast, CCL7-deficiency led to greater parasite dissemination and poor parasite control in the spleen. Our studies reveal a novel role for CCL7 in negatively regulating cutaneous inflammation, specifically neutrophils, early during L. major infection. We propose that CCL7-mediated dampening of the early immune response in the skin may limit the ability of the parasite to disseminate without compromising cutaneous control.
format Online
Article
Text
id pubmed-6331479
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63314792019-01-22 CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection Ford, Jill Hughson, Angela Lim, Kihong Bardina, Susana V. Lu, Wuyuan Charo, Israel F. Lim, Jean K. Fowell, Deborah J. Front Immunol Immunology The chemokine CCL7 (MCP3) is known to promote the recruitment of many innate immune cell types including monocytes and neutrophils to sites of bacterial and viral infection and eosinophils and basophils to sites of allergic inflammation. CCL7 upregulation has been associated with many inflammatory settings including infection, cardiovascular disease, and the tumor microenvironment. CCL7's pleotropic effects are due in part to its ability to bind numerous chemokine receptors, namely CCR1, CCR2, CCR3, CCR5, and CCR10. CCL7-blockade or CCL7-deficiency is often marked by decreased inflammation and poor pathogen control. In the context of Leishmania major infection, CCL7 is specifically upregulated in the skin one-2 weeks after infection but its role in L. major control is unclear. To determine CCL7's impact on the response to L. major we infected WT and CCL7(−/−) C57BL/6 mice. L. major infection of CCL7-deficient mice led to an unexpected increase in inflammation in the infected skin 2 weeks post-infection. A broad increase in immune cell subsets was observed but was dominated by enhanced neutrophilic infiltration. Increased neutrophil recruitment was associated with an enhanced IL-17 gene profile in the infected skin. CCL7 was shown to directly antagonize neutrophil migration in vitro and CCL7 add-back in vivo specifically reduced neutrophil influx into the infected skin revealing an unexpected role for CCL7 in limiting neutrophil recruitment during L. major infection. Enhanced neutrophilic infiltration in CCL7-deficient mice changed the balance of L. major infected host cells with an increase in the ratio of infected neutrophils over monocytes/macrophages. To determine the consequence of CCL7 deficiency on L. major control we analyzed parasite load cutaneously at the site of infection and viscerally in the draining LN and spleen. The CCL7(−/−) mice supported robust cutaneous parasite control similar to their WT C57BL/6 counterparts. In contrast, CCL7-deficiency led to greater parasite dissemination and poor parasite control in the spleen. Our studies reveal a novel role for CCL7 in negatively regulating cutaneous inflammation, specifically neutrophils, early during L. major infection. We propose that CCL7-mediated dampening of the early immune response in the skin may limit the ability of the parasite to disseminate without compromising cutaneous control. Frontiers Media S.A. 2019-01-08 /pmc/articles/PMC6331479/ /pubmed/30671055 http://dx.doi.org/10.3389/fimmu.2018.03063 Text en Copyright © 2019 Ford, Hughson, Lim, Bardina, Lu, Charo, Lim and Fowell. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ford, Jill
Hughson, Angela
Lim, Kihong
Bardina, Susana V.
Lu, Wuyuan
Charo, Israel F.
Lim, Jean K.
Fowell, Deborah J.
CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection
title CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection
title_full CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection
title_fullStr CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection
title_full_unstemmed CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection
title_short CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection
title_sort ccl7 is a negative regulator of cutaneous inflammation following leishmania major infection
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331479/
https://www.ncbi.nlm.nih.gov/pubmed/30671055
http://dx.doi.org/10.3389/fimmu.2018.03063
work_keys_str_mv AT fordjill ccl7isanegativeregulatorofcutaneousinflammationfollowingleishmaniamajorinfection
AT hughsonangela ccl7isanegativeregulatorofcutaneousinflammationfollowingleishmaniamajorinfection
AT limkihong ccl7isanegativeregulatorofcutaneousinflammationfollowingleishmaniamajorinfection
AT bardinasusanav ccl7isanegativeregulatorofcutaneousinflammationfollowingleishmaniamajorinfection
AT luwuyuan ccl7isanegativeregulatorofcutaneousinflammationfollowingleishmaniamajorinfection
AT charoisraelf ccl7isanegativeregulatorofcutaneousinflammationfollowingleishmaniamajorinfection
AT limjeank ccl7isanegativeregulatorofcutaneousinflammationfollowingleishmaniamajorinfection
AT fowelldeborahj ccl7isanegativeregulatorofcutaneousinflammationfollowingleishmaniamajorinfection